China Stock - Potential Uptrend, Need More ObservationIf there's an upside pivot in CBIdx that RSI can cross the two MAs, as well as an upside cross in Aroon, then an uptrend is formed aiming for a peak by the end of November.
0.80EUR
290.81 MEUR
993.46 MEUR
27.55 M
About ASYMCHEM LAB.(TIAN.)H YC1
Sector
Headquarters
Tianjin
Employees (FY)
9.79 K
Website
Founded
1998
ISIN
CNE100004Z06
FIGI
BBG01450KDG6
Asymchem Laboratories (Tianjin) Co., Ltd. engages in the research and development, and production of intermediates, and active pharmaceutical ingredients. Its business scopes include small molecule contract development and manufacturing organization (CDMO), and emerging service businesses. Its Small Molecule CDMO business provides process development and analysis, clinical drug production, new drug application and approval services, and current good manufacturing practice commercial production services. Its Emerging Service business covers chemical macromolecules, formulations, biosynthesis technology, biological macromolecules, and clinical research services. The company was founded by Hao Hong on October 7, 1998 and is headquartered in Tianjin, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ASYMCHEM LAB.(TIAN.)H YC1 stocks are traded under the ticker 7K90.
ASYMCHEM LAB.(TIAN.)H YC1 is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ASYMCHEM LAB.(TIAN.)H YC1 has a max estimate of 22.55 EUR and a min estimate of 9.60 EUR.
7K90 earnings for the last quarter are 0.19 EUR whereas the estimation was 0.13 EUR which accounts for 44.76% surprise. Estimated earnings for the next quarter are 0.05 EUR. See more details about ASYMCHEM LAB.(TIAN.)H YC1 earnings.
ASYMCHEM LAB.(TIAN.)H YC1 revenue for the last quarter amounts to 227.46 M EUR despite the estimated figure of 257.54 M EUR. In the next quarter revenue is expected to reach 225.78 M EUR.
Yes, you can track ASYMCHEM LAB.(TIAN.)H YC1 financials in yearly and quarterly reports right on TradingView.
7K90 net income for the last quarter is 7.36 M EUR, while the quarter before that showed 68.29 M EUR of net income which accounts for −89.22% change. Track more ASYMCHEM LAB.(TIAN.)H YC1 financial stats to get the full picture.
Yes, 7K90 dividends are paid annually. The last dividend per share was 0.23 EUR. As of today, Dividend Yield (TTM)% is 3.33%. Tracking ASYMCHEM LAB.(TIAN.)H YC1 dividends might help you take more informed decisions.
ASYMCHEM LAB.(TIAN.)H YC1 dividend yield was 1.98% in 2023, and payout ratio reached 25.99%. The year before the numbers were 1.73% and 18.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 7K90 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASYMCHEM LAB.(TIAN.)H YC1 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 9.79 K employees. See our rating of the largest employees — is ASYMCHEM LAB.(TIAN.)H YC1 on this list?
We've gathered analysts' opinions on ASYMCHEM LAB.(TIAN.)H YC1 future price: according to them, 7K90 price has a max estimate of 22.57 EUR and a min estimate of 9.59 EUR. Read a more detailed ASYMCHEM LAB.(TIAN.)H YC1 forecast: see what analysts think of ASYMCHEM LAB.(TIAN.)H YC1 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASYMCHEM LAB.(TIAN.)H YC1 EBITDA is 348.53 M EUR, and current EBITDA margin is 34.87%. See more stats in ASYMCHEM LAB.(TIAN.)H YC1 financial statements.